The Phase 3 SYNERGY trial (NCT06859268) will evaluate whether retatrutide can resolve steatohepatitis (liver inflammation) and fibrosis, endpoints that would be required for regulatory approval specifically for liver disease treatment
Velocity Partners VC led the round with co-leaders Evercurious VC, alongside major participation from Relativity Healthcare Partners
Access can change as evidence and regulatory decisions change
Leading Companies Delivering GLP-1 Nutritional Support Solutions Leading Company - Nestl Health Science Industry Share - 18% In the GLP-1 nutritional support market, leading players are leveraging clinical positioning, micronutrient optimization, and bariatric-friendly formats to target consumers on GLP-1 therapies such as semaglutide and tirzepatide
Titrating slowly helps the gastrointestinal system adapt to the delayed gastric emptying and appetite suppression effects
Kind Patches says its products are tested by independent third-party laboratories, and that it uses proven supplement ingredients that our customers suggest and demand. Companies selling the patches often tout that the ingredients bypass the digestive system this way and go straight into the bloodstream, but thats actually a concern, White says
